Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) Employee Directory
BiotechnologyWashington, United States51-200 Employees
Alder Biopharmaceuticals is a mid-sized biotechnology company focused on migraine treatment through the discovery, development, and potential commercialization of monoclonal antibody therapies. It aims to transform migraine care and improve the lives of people affected by the condition, acknowledging that migraine can also impact caregivers. The company notes that some employees experience migraine themselves, a factor informing its research approach to patient needs. Its work centers on applying monoclonal antibody expertise to develop preventive therapies for migraine. Based in Bothell, Washington, Alder operates in the biotechnology research sector with a portfolio of antibody programs for migraine prevention, including ALD1910 and eptinezumab. In 2019, the company conducted commercial readiness activities for eptinezumab in the United States as it advanced toward a potential launch.
1-888-653-2347 
support@leadiq.com 
